GlassScriptPhysician profile
Shun Sunder
NPI 1376557132
$608.50
in general payments reported to CMS, 2019-2025
16 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.39 · 2022: $13.89 · 2023: $200 · 2024: $239 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $560.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $560.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $114.26 | 2024-2025 | Impella |
| Lexicon Pharmaceuticals, INC. | $78.87 | 2023-2024 | Inpefa |
| E.R. Squibb & Sons, L.L.C. | $73.20 | 2023-2025 | Eliquis, Camzyos |
| Novartis Pharmaceuticals Corporation | $44.77 | 2025 | |
| Irhythm Technologies, INC. | $38.65 | 2023 | Zio Xt Patch |
| Merck Sharp & Dohme LLC | $36.89 | 2024 | Verquvo |
| Kestra Medical Technology Services, INC. | $34.24 | 2023 | Assure Wcd |
| Bayer Healthcare Pharmaceuticals INC. | $33.39 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $32.53 | 2022-2024 | Farxiga |
| Kiniksa Pharmaceuticals International, Plc | $27.82 | 2024 | Arcalyst |
| Biotronik INC. | $21.94 | 2019 | |
| Scpharmaceuticals INC. | $17.59 | 2024 | |
| Kiniksa Pharmaceuticals, LTD. | $14.65 | 2023 | Arcalyst |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.72 | 2024 | Jardiance |
| Alnylam Pharmaceuticals INC. | $13.53 | 2023 | Onpattro |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $12.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shun Sunder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.